Back to CVE records
Medium 6.1Published May 8, 2026

CVE-2026-42794Improper Neutralization of Input During Web Page Generation (XSS) vulnerability in absinthe-graphql absinthe_plug allows reflected cross-site scripting via the GraphiQL interface.

Updated under an hour ago ()

Does this affect you?

It affects absinthe-graphql absinthe.plug. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

Improper Neutralization of Input During Web Page Generation (XSS) vulnerability in absinthe-graphql absinthe_plug allows reflected cross-site scripting via the GraphiQL interface. 'Elixir.Absinthe.Plug.GraphiQL':js_escape/1 in lib/absinthe/plug/graphiql.ex escapes single quotes and newlines in the query GET parameter before embedding it in an inline JavaScript string, but does not escape backslashes. An attacker can bypass the escaping by prefixing a quote with a backslash (e.g. \'), breaking out of the string context and executing arbitrary JavaScript in the victim's browser. This issue affects absinthe_plug: from 1.2.0 before 1.5.10.

CVSS
6.1 MEDIUM (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
Weakness (CWE)
CWE-79
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
Not given
NVD analysis
Analyzed
Record last updated
Jun 17, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
absinthe-graphql absinthe.plug
absinthe-graphql:absinthe.plug
from 1.2.0 before 1.5.10
NVD

References

  • third-party-advisory
  • patch
  • issue-tracking
  • third-party-advisory

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.